Pakistan

Five Major Pharma Firms Exit Manufacturing in Pakistan

Share
Pharma Firms

Web Desk: Five leading multinational Pharma Firms have exited or transferred their manufacturing operations in Pakistan over the past three years, the National Assembly was told on Friday. Health Minister Syed Mustafa Kamal confirmed that Bayer, ICI Pakistan, Sanofi-Aventis, Pfizer and Novartis have all divested their local production facilities, handing over operations to domestic firms

Operations Continue Under New Management


The minister clarified that the facilities remain operational under new ownership, ensuring that the supply of essential medicines is maintained without interruption. He described the moves as a “strategic shift” rather than a complete shutdown of production lines.

List of Divested Units


The divestments include Bayer’s Lahore plant, ICI Pakistan’s multi-city operations, Sanofi’s Korangi industrial unit, Pfizer’s S.I.T.E. Karachi facility and Novartis’ West Wharf site. Apart from Pharma Firms several multinational companies have also halted their operations in Pakistan.

No Reasons Provided


The National Assembly briefing did not provide specific reasons for the companies’ decisions to divest. Analysts suggest such moves often reflect global strategic priorities or local market adjustments rather than immediate business failures.

Read more: Karachi University Pharmacy students create Innovative solutions

Transparency

Our editorial standards

Azaad Digital publishes reporting under its editorial standards. If you spot an error or want to share feedback, our newsroom provides clear routes for corrections and contact.

zaryun pervaiz
Written by

zaryun pervaiz

The writer is a political analyst covering politics, national security, foreign affairs, policy shifts in South Asia and beyond, energy and economy.

Link copied